Firstly, by controlling the expression of MAFbx/atrogin-1 and MurF1 in the early phase of atrophy development as demonstrated by others [28] and secondly by controlling the expression of APAF-1/Caspase 9 in the late phase of atrophy development as proposed in our study. The gene discussed is CASP9; the disease is Atrophy.